Skip to main content
Erschienen in: Journal of Neurology 7/2018

08.05.2018 | Original Communication

Haemorrhagic stroke related to the use of 4-fluoroamphetamine

verfasst von: C. H. W. Wijers, M. C. Visser, R. T. H. van Litsenburg, R. J. M. Niesink, R. B. Willemse, Esther A. Croes

Erschienen in: Journal of Neurology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The use of the new psychoactive substance 4-fluoroamphetamine (4-FA) and the number of 4-FA-related intoxications substantially increased in The Netherlands in recent years. We describe two patients with severe 4-FA-related complications and the characteristics of a large sample of 4-FA-intoxicated patients.

Methods

Information on patients with 4-FA-related intoxications between January 2009 and June 2017 was available from the Monitor Drug-related Incidents. Detailed clinical information was obtained of two patients with haemorrhagic stroke after toxicologically confirmed 4-FA use.

Results

We report on two patients who presented with headache and mild hypertension after 4-FA use. Patient A developed one-sided weakness and decreased consciousness after a few hours. A computed tomography scan showed a left-sided intracerebral haemorrhage. Because of life-threatening cerebral herniation, haematoma evacuation was performed. Postoperatively, she suffered from a right-sided hemiparalysis and severe aphasia, requiring clinical rehabilitation. Patient B had a subarachnoid haemorrhage without neurological deficits. In total, 939 4-FA-intoxicated patients were registered. These patients used 4-FA alone (44%) or in combination with alcohol (13%) and/or other drugs (43%).

Discussion

Patients using 4-FA are at risk for life-threatening health problems, including intracranial haemorrhage. Additional brain imaging should be considered in 4-FA-intoxicated patients, not only in the presence of neurological deficits, but also in the case of severe headache.
Literatur
3.
Zurück zum Zitat Linsen F, Koning RP, Van Laar M, Niesink RJ, Koeter MW, Brunt TM (2015) 4-Fluoroamphetamine in The Netherlands: more than a one-night stand. Addiction 110:1138–1143CrossRefPubMed Linsen F, Koning RP, Van Laar M, Niesink RJ, Koeter MW, Brunt TM (2015) 4-Fluoroamphetamine in The Netherlands: more than a one-night stand. Addiction 110:1138–1143CrossRefPubMed
4.
Zurück zum Zitat Hondebrink L, Nugteren-van Lonkhuyzen JJ, Van Der Gouwe D, Brunt TM (2015) Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre. Drug Alcohol Depend 147:109–115CrossRefPubMed Hondebrink L, Nugteren-van Lonkhuyzen JJ, Van Der Gouwe D, Brunt TM (2015) Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre. Drug Alcohol Depend 147:109–115CrossRefPubMed
5.
Zurück zum Zitat Wijers CHW, Van Litsenburg RTH, Hondebrink L, Niesink RJM, Croes EA (2017) Acute toxic effects related to 4-fluoroamphetamine. Lancet 389:600CrossRefPubMed Wijers CHW, Van Litsenburg RTH, Hondebrink L, Niesink RJM, Croes EA (2017) Acute toxic effects related to 4-fluoroamphetamine. Lancet 389:600CrossRefPubMed
6.
Zurück zum Zitat Nugteren-van Lonkhuyzen JJ, Van Riel AJHP., Brunt TM, Hondebrink L (2015) Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug Alcohol Depend 157:18–27CrossRefPubMed Nugteren-van Lonkhuyzen JJ, Van Riel AJHP., Brunt TM, Hondebrink L (2015) Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug Alcohol Depend 157:18–27CrossRefPubMed
7.
Zurück zum Zitat Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132–137CrossRefPubMed Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132–137CrossRefPubMed
8.
Zurück zum Zitat Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011) In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbicdopamine transmission in the rat. J Pharmacol Exp Ther 337:218–225CrossRefPubMedPubMedCentral Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011) In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbicdopamine transmission in the rat. J Pharmacol Exp Ther 337:218–225CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Al-Abri S, Meier KH, Colby JM, Smollin CG, Benowitz NL (2014) Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels. Clin Toxicol (Phila) 52:1292–1295CrossRef Al-Abri S, Meier KH, Colby JM, Smollin CG, Benowitz NL (2014) Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels. Clin Toxicol (Phila) 52:1292–1295CrossRef
10.
Zurück zum Zitat Wolf CE, Poklis JL, Cumpston K, Moss M, Poklis A (2017) Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Test Anal 9:657–659CrossRefPubMed Wolf CE, Poklis JL, Cumpston K, Moss M, Poklis A (2017) Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Test Anal 9:657–659CrossRefPubMed
11.
Zurück zum Zitat Laskowski LK, Landry A, Vassallo SU, Hoffman RS (2015) Ice water submersion for rapid cooling in severe drug-induced hyperthermia. Clin Toxicol (Phila) 53:181–184CrossRef Laskowski LK, Landry A, Vassallo SU, Hoffman RS (2015) Ice water submersion for rapid cooling in severe drug-induced hyperthermia. Clin Toxicol (Phila) 53:181–184CrossRef
12.
Zurück zum Zitat Knippels MCJ, Essers IMM, Magdelijns FJH, Van Twist DJL (2017) Ecstasy-light’—not as light as its name suggests: toxic effects of 4-fluoroamphetamine. Ned Tijdschr Geneeskd 16:D1356 Knippels MCJ, Essers IMM, Magdelijns FJH, Van Twist DJL (2017) Ecstasy-light’—not as light as its name suggests: toxic effects of 4-fluoroamphetamine. Ned Tijdschr Geneeskd 16:D1356
15.
Zurück zum Zitat Yeung M, Bhalla A, Birns J (2011) Recreational drug misuse and stroke. Curr Drug Abuse Rev 4:286–291CrossRefPubMed Yeung M, Bhalla A, Birns J (2011) Recreational drug misuse and stroke. Curr Drug Abuse Rev 4:286–291CrossRefPubMed
16.
17.
18.
Zurück zum Zitat Cappelen-Smith C, Calic Z, Cordato D (2017) Reversible cerebral vasoconstriction syndrome: recognition and treatment. Curr Treat Options Neurol 19:21CrossRefPubMed Cappelen-Smith C, Calic Z, Cordato D (2017) Reversible cerebral vasoconstriction syndrome: recognition and treatment. Curr Treat Options Neurol 19:21CrossRefPubMed
Metadaten
Titel
Haemorrhagic stroke related to the use of 4-fluoroamphetamine
verfasst von
C. H. W. Wijers
M. C. Visser
R. T. H. van Litsenburg
R. J. M. Niesink
R. B. Willemse
Esther A. Croes
Publikationsdatum
08.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 7/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8888-6

Weitere Artikel der Ausgabe 7/2018

Journal of Neurology 7/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.